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Abstract

INTRODUCTION: The high incidence of peripheral nerve injury (PNI) in conventional cardiac
surgery (CCS) is believed to result from mechanical injury during sternotomy and/or retraction
of the sternum. Minimally invasive cardiac surgery (MICS) is a type of cardiac surgery which
does not require sternotomy or retraction of the sternum. Since surgery related PNI can lead to
serious problems for both the patients and care providers, the incidence and details of PNI in
cardiac surgery needs to be investigated.
OBJECTIVE: To compare the degree of nerve injury in MICS and CCS using somatosensory
evoked potential (SSEP) signals. METHODS: 51 participants were prospectively observed
during surgery for abnormal SSEP signals. SSEP signals were obtained using EPAD®. Also, all
participants were assessed pre and postoperatively for neurological symptoms involving bilateral
upper limbs. RESULTS: Full or partial SSEP data were obtained from 41 participants. There
was a significant difference (P=0.031) in abnormal SSEP signals between the CCS (n=22) and
MICS (n=19) groups. More abnormal SSEP signals were observed in CCS group compared to
MICS group. Abnormal SSEP signals were observed independently of sternotomy or sternal
retraction. CONCLUSIONS: This study suggests that CCS is associated with more
intraoperative nerve injury when compared with MICS. Future studies should focus on
preventive and interventional strategies against perioperative nerve injury.

Keywords
Peripheral Nerve Injury, Minimally Invasive Cardiac Surgery, Conventional Cardiac Surgery,
SomatoSensory Evoked Potential, Observational Prospective Cohort Study
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1 Introduction
1.1 Peripheral Nerve Injuries (PNI)
Peripheral nerve injury is defined as partial or complete loss of motor or sensory function or
both. Nerves of interest in this thesis includes the brachial plexus, ulnar nerve, median nerve and
radial nerve. Since surgery related damage to nerves in the lower extremities is rare1 and not
related to the main focus of the current study, they will not be described in this thesis.

PNI are a known complication associated with any type of surgery. According to one report,1, 2
out of 1,541 claims filed for PNI with the American Society of Anesthesiologists, 227 (15%) are
anesthesia-related. PNI incidence in cardiac surgery ranges from 0.5% to 38%, the most
prevalent being brachial plexus injury (0.5–38%)3-7 followed by ulnar nerve injury (1.9–24%)4, 810

Other PNIs include saphenous nerve injury, phrenic nerve injury and carpal tunnel syndrome.

The clinical significance of PNI is as follows; with sensory deficit, patients frequently complain
of a tingling or numb sensation in the upper extremities. This predisposes patients to certain
injuries, such as burns, falls and/or subsequent bone fractures. With motor deficits, patients have
trouble holding objects and have difficulty with activities of daily living. Since both the motor
and sensory deficits are debilitating and impact patients’ daily lives negatively, research
regarding this field is of high clinical significance.

The exact mechanisms of injury is unclear and under investigation. However, one study2
demonstrated the incidence of PNI in noncardiac surgery to be 0.03% while that in cardiac
surgery was around 15%.3 This high incidence of PNI in cardiac surgery is very concerning to
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cardiac surgeons and anesthesiologists. Proposed mechanisms for PNIs in cardiac surgery
include patient’s position, sternotomy, sternal retraction, the use of CardioPulmonary Bypass
(CPB), systemic inflammation and hypothermia.3, 8, 9, 11, 12
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1.2 Anatomy of the Upper Extremity

Brachial plexus

Clavicle
First rib

Figure 1. 1 Brachial plexus passing through the clavicle and the first rib13

The Brachial plexus is a group of nerves and consists of the upper root (C5 - 6), the middle root
(C7) and the lower root (C8 - T1), where C stands for cervical nerve and T stands for thoracic
nerve. (Figure 1.1)
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Figure 1. 2 Innervation of C5 to T1 to the upper extremety13

The upper root innervates the lateral side of the arm/hand and, the middle root innervates the
mid-portion of the arm/hand and the lower root innervates the medial side of the arm/hand.
(Figure 1.2) The roots further merge or branch off to form the ulnar nerve, median nerve and
radial nerve.

Figure 1. 3 Sensory innervation to the hand13
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The ulnar nerve originates from the lower root (C8 - T1) and innervates the medial side of the
hand. The sensory innervation is depicted in Figure 1.3. The motor function includes adduction
of the thumb and flexion of the hand, 4th and 5th digits. In detail, the ulnar nerve innervates the
following muscles; flexor carpi ulnaris, flexor digitorum profundus, opponens digiti minimi,
abductor digiti minimi, flexor digiti minimi brevis, the third and fourth lumbrical muscles, dorsal
interossei, palmar interossei, adductor pollicis, flexor pollicis brevis and palmaris brevis.

The median nerve originates from the upper root (C5 - C6) and the lower root (C8 - T1). The
sensory innervation is depicted in Figure 1.3. The motor function includes flexion of radial half
of digits and thumb, abduction and opposition of thumb. In detail, the median nerve innervates
the following muscles; pronator teres, flexor carpi radialis, palmaris longus, flexor digitorum
superficialis muscle, flexor digitorum profundus, flexor pollicis longus and pronator quadratus.

The radial nerve originates from C5-T1. The sensory innervation is depicted in Figure 1.3. The
motor function includes extension of the hand and extension of the fingers. In detail, the radial
nerve innervates the following muscles; triceps brachii, anconeus, brachioradialis, extensor carpi
radialis longus, deep branch of the radial nerve, extensor carpi radialis brevis, supinator,
posterior interosseous nerve, extensor digitorum, extensor digiti minimi, extensor carpi ulnaris,
abductor pollicis longus, extensor pollicis brevis, extensor pollicis longus and extensor indicis.

1.3 Characteristics and Mechanism of PNI in Cardiac Surgery
According to one study11 involving 421 patients undergoing CABG, 63 new peripheral nerve
lesions occurred in 55 patients (13%). In this study, neurological assessment was performed
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preoperatively and postoperatively on Post-Operative Day (POD) 3 or 4. The same study showed
an ulnar neuropathy incidence of 1.9–18.3%, a brachial plexus injury rate of 5–10% and a
phrenic nerve injury rate of 30–70%. All the brachial plexus injuries and 4 out of 5 ulnar
neuropathies occurred in the left arm. Of the 23 patients who had brachial plexus injury, 21 had
lower trunk or medial cord injuries. In this study, all the nerve injuries were assessed by
neurologists, and patients who showed neurological deficits were determined to have nerve
injury. Most of the injuries were transient, and lasting disability was rare.

Ben-David et al.14 demonstrated that PNI in cardiac surgery is associated with lower root injury
whereas in noncardiac surgery, upper or middle roots are involved. (See Figure 1.1 for details of
upper and middle roots) This suggests that PNI in cardiac surgery is frequently caused by
mechanical injury to the lower root because of its proximity to the sternotomy and the retracted
structures. The same authors also showed that post–cardiac surgery PNIs are mainly associated
with sensory deficit, and the motor function is rarely affected, presumably because sensory
function is more likely to be damaged with mechanical injuries compared to motor function. One
possible explanation is that sensory nerve responses decrease more and recover less than motor
nerve responses in the presence of ischemia. This may be due to the difference in diameter
between two nerve groups and/or faster inexcitability of sensory nerve during ischemia. 15

Unlu et al.5 conducted a retrospective study investigating 575 patients undergoing cardiac
surgery. All the patients underwent cardiac surgery under moderate hypothermia (30–32℃) and
were evaluated for symptoms and signs of neurologic deficits related to brachial plexus
dysfunction prior to surgery. Examination consisted of a detailed past medical history and
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thorough examination of upper motor and sensory function. Patients were reexamined within
three days of weaning from the ventilator. When a difference was found, the patients were sent
for additional examinations, such as electromyogram (EMG) and nerve conduction tests. The
study found a 0.5% incidence of brachial plexus injury. This study has one of the lowest
incidences in the literature and the underlying reason would be as follows; in this study,
postoperative screening was performed by the bedside nurse. It is highly possible that specialists
would have been able to detect patients with minor or subtle symptoms that the bedside nursed
might have missed,

One prospective study16 investigating patients undergoing CABG showed that the rate of
brachial plexus injury was 11% in those receiving ITA harvest compared with 1% in those who
did not receive it.

Another prospective study7 investigating 1,000 patients undergoing CABG, valve or valve plus
CABG showed that 27 patients developed PNIs. PNIs were found in 21 of 198 patients who
underwent internal thoracic artery (ITA) harvest, 4 out of 205 patients, 1 out of 521 patients and
4 out of 47 patients who underwent valve surgery, CABG and CABG plus valve surgery,
respectively. The most frequent lesions were at C7-T1 (21 patients), while 6 patients had upper
trunk lesions (C5,C6). Overall, risk factors included DM, preexisting neuropathy, peripheral
vascular disease, low BMI, hypothermia, and ITA harvest. Another study17 involving 374
patients undergoing CABG, valve surgery or aortic surgery showed 6.1% of the patients
developed 34 new PNIs; 4 with brachial plexus injury (all on the left side), 4 with carpal tunnel
syndrome and 3 developed worsening preexisting neuropathies. In this study, diabetes mellitus

7

(DM) was found to be the only risk factor.

Jellish et al.18 studied three different types of asymmetric retractors using 60 patients undergoing
CABG using SomatoSensory Evoked Potential (SSEP) monitoring. They found that one type of
retractor, the Delacroix-Chevalier, to be associated with an incidence of brachial plexus injury
based on SSEP change of 5% whereas other types of retractors, the Pittman and Rultract groups,
had incidences of 25% and 45%, respectively. In addition, the authors found no differences in
actual incidences of symptomatic PNI (Rultract 1.5%, Delacroix-Chevalier 0.5%, Pittsman
1.5%) when the postoperative neurological examination was performed by a blinded nurse
practitioner. This study suggested that the types of retractors may have an impact the
postoperative incidence of PNI7.

In another study,8, 9 the authors used cadavers to investigate the positions of sternal retraction.
They found that when the sternal retractor was put in a high position (second intercostal
position), 7 out of 10 cadavers developed fractures of the first rib while no fractures were
observed when the sternal retractor was put in a lower position (4th intercostal position). Since
the brachial plexus passes through the first rib and the clavicle (Figure1.1), mal-positioning of
the retractor may also result in PNI in cardiac surgery.

Also, in cardiac surgery, all the patients receive an arterial line in the radial artery (Figure 1.4).
According to the latest report19, the rate of radial nerve injury after radial arterial line insertion is
0.03%. With this low incidence rate, no research has been done regarding the mechanisms of
injury. However, direct mechanical injury caused by needle insertion is said to be the most likely
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etiology.

1.3.1 Sternotomy and Sternal Retraction
Sternotomy is a surgical procedure in which a horizontal incision is made on the sternum. After
sternotomy, the sternum is divided into two pieces and retracted to expose the underlying
structures, such as the heart and major arteries. (Figure 1.4)

Figure 1. 4 Sternotomy and retractor. (Left. Sternal retractor Morse®; Right. Sternal retraction)20

One cadaver study12 showed that when the sternal retractor is fully opened, the clavicles are
pushed into the retroclavicular space, and the first ribs are rotated superiorly. As a result, the
brachial plexus becomes stretched, causing mechanical injury to the nerve plexus.
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1.3.2 Sternal Retraction for ITA Harvest
In CABG, the left internal thoracic artery (ITA) is always used as a graft to the left anterior
descending artery unless the graft is deemed unusable because of its small caliber or the
obstructed lumen. During ITA harvest, the sternum needs to be retracted using a sternal retractor
(Figure 1.5) and the likelihood of mechanical injuries to the brachial plexus is said to be higher
due to extension of, or the direct injury to, the brachial plexus.

Figure 1. 5 Retractor for ITA harvest (Left. Couetil® ITA retractor; Right. Sternal retraction for
ITA harvest)21

The brachial plexus (Figure 1.1) is a network of nerves that is composed of the cervical nerves
C5 to C8 and the thoracic nerve T1. Brachial plexus injury is said to occur due to overextension
with traction force during sternal retraction (indirect injury) and/or compression of the brachial
plexus between the first rib and the clavicle (direct injury)22.

In one study23, the authors studied 44 patients undergoing CABG using SSEP monitoring. In that
study, 18% of the patients who had sternal retraction for ITA harvest had brachial plexus
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symptoms, while only one patient who did not have sternal retraction for ITA harvest had
neurological symptoms. In the patients who required ITA harvest, SSEP signals did not show
prolonged latency after removal of the retractors. SSEP showed reduced amplitude in 71% of the
patients during retraction. The SSEP amplitude change recovered to some extent as soon as the
retractors were removed but never returned to baseline levels. This study indicates that sternal
retraction for ITA harvest plays a major role in the etiology of PNI in cardiac surgery.

1.3.3 CPB, Systemic Inflammation
To date, there is no strong evidence that suggests that the use of CPB is directly associated with
PNI in cardiac surgery. However, some researchers believe that the high incidence of PNI in
cardiac surgery cannot be explained solely by the mechanical injuries and that the use of CPB
and the concomitant systemic inflammation and/or hypothermia may play an important role in
the etiology of PNI. Since cardiac surgeries of interest in the current study do not require
hypothermia, it will not be described in detail in this thesis. In one study3, SSEP changes occur
one hour after the CPB started. The results of this study suggest that systemic inflammation
resulting from the use of CPB accumulates insults to the nerves over time, resulting in nerve
injury.

1.3.4 Double Crush Theory
Upton et al.24 first hypothesized the double crush theory. They postulated that preexisting
neuropathy makes patients susceptible to carpal tunnel syndrome. They investigated 115 patients
with carpal tunnel syndrome and found that 70% of them had either generalized neuropathy or
cervical neuropathy as an underlying pathology. Based on this concept, many researchers started
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believing that PNI in cardiac surgery does not result from one single trigger but rather a
combination of multiple insults to the nerves. This may explain the finding that DM is frequently
identified as a risk factor for PNI, as DM is also known to cause microangiopathy with
accompanying peripheral nerve injury3, 17, 25, 26.

According to another study27 with 42 patients undergoing cardiac surgery (31 patients had
CABG, 3 had valve replacement, 2 had combined surgery, 3 underwent redo CABG, and 3 had
complex surgery involving revision CABG), 11 patients (26%) clinically demonstrated
postoperative neuropathy. All these patients had pre-existing lesions and there was a direct
correlation between preoperative deceleration of ulnar nerve conduction and postmedian
sternotomy neuropathy.

In summary, numerous studies suggest that PNI is common following cardiac surgery, and the
incidence is much higher than that of general surgery. Regarding the characteristics of PNI, it
involves predominantly the sensory functions of the lower root nerve distribution in the left
upper extremity. It is increased by sternal retraction, and specific types of sternal retractors are
more prone to cause PNI than others, indicating the retraction of the sternum for ITA harvest add
further insults to vulnerable nerves. Pre-existing neuropathy makes PNI more common as does
DM. We therefore would expect that MICS (See 1.5 for detail, minimally invasive cardiac
surgery) would have the lower incidence of PNI than CCS (See 1.4 for detail, conventional
cardiac surgery), and that during sternal retraction and ITA harvest in CCS, abnormal SSEP
signals, which indicate nerve injury, should be more commonly observed than at other times in
either CCS or MICS.
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1.4 Conventional Cardiac Surgery (CCS)

Arterial line
Medial nerve
Ulnar nerve

Figure 1. 6 An arterial line in the radial artery and anatomical positions of median and ulnar
nerves.

CCS in this study is defined as surgery that requires median sternotomy (See Figure 1.4) and
CPB. Median sternotomy is performed by making an incision on the sternum and dividing the
sternum into two pieces. The divided sternum is then retracted to expose the underlying
structures (See Figure 1.5), such as the heart and major vessels. Most commonly, CCS is
performed with the use of CPB. CPB is composed of two cannulae, i.e. the aortic and venous, the
membrane oxygenator, the pump and the tubing. The aortic cannula is usually inserted into the
ascending aorta and the venous cannula is inserted into the right atrium. During CCS, a patient’s
heart is completely bypassed by the CPB machine to expose intracardiac structures of interest or
to facilitate the surgical procedures. In the current study, participants undergoing CABG surgery
or aortic valve replacement (AVR) surgery are included in the CCS group.

Regarding intraoperative positioning, CCS is performed in supine position with bilateral arms
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padded and protected with soft towels.

1.4.1 Coronary Artery Bypass Graft (CABG)
Most cardiac surgeons perform coronary anastomoses with CPB. The ITA is the most commonly
used graft for an anastomosis to the left anterior descending artery. The actual surgical procedure
is as follows: after induction of anesthesia, a triple lumen central line is inserted into the right
internal jugular vein. Subsequently, the surgery is initiated via median sternotomy. Sternal
retraction is achieved with a sternal retractor and the left ITA is harvested with ITA retractor
placed on the sternum. After the graft is optimized for anastomosis, heparin is administered, and
ascending aorta and right atrial cannula are inserted, and CPB is started. Necessary anastomoses
are made on the arrested heart, and CPB is weaned. The sternum is closed with metal wires, and
the patient is brought to the intensive care unit.

1.4.2 Aortic Valve Replacement (AVR)
After the induction of general anesthesia, median sternotomy is performed, followed by heparin
administration, cannulation and initiation of CPB. Upon the confirmation of induced asystole,
the ascending aorta is opened and the aortic valve replaced the aorta is closed and CPB is
weaned. The sternum is closed with metal wires, and the patient is brought to the intensive care
unit.

1.5 Minimally Invasive Cardiac Surgery (MICS)
MICS is defined as surgeries that do not require median sternotomy nor CPB. It is performed
worldwide for its unique benefits of fast recovery and small surgical incisions. Other advantages
of MICS may include short length of hospital stay, and less bleeding. In the current study,
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patients undergoing transcatheter aortic valve implantation (TAVI) surgery or robotic CABG
surgery are included in this group.

MICS is usually performed in 30-45°lateral position with bilateral arms padded and protected
with soft towels in the same way as CCS.

1.5.1 Transcatheter Aortic Valve Implantation (TAVI)
TAVI was first performed in France in 2002 on a patient with aortic stenosis28. TAVI does not
require sternotomy, retraction of the sternum or CPB. There are two ways to approach the aortic
valve, i.e. transfemoral and transapical approach. Transfemoral approach is done with incision on
the groin, and transapical approach is performed with incision in the lateral chest wall.

1.5.2 Robotic CABG29
Robotic CABG has been performed over the last 20 years in selected institutions. Patient
selection depends on anatomy, comorbidities, and number of lesions. This procedure does not
require, sternotomy, retraction of the sternum or CPB. This procedure is performed with a small
incision in the left lateral chest wall.

1.6 Somatosensory Evoked Potential (SSEP)30, 31
In SSEP, surface electrodes produce a signal at the site of the peripheral nerve, and another
electrode at the back of the neck receives the signal. When a neuron gets stimulated, it generates
an electric signal, which then gets propagated. Recording electrodes measure this compound
evoked action potential. While electroencephalograms (EEG) record the brains’ spontaneously
15

generated electrical activity over short periods, SSEP is time-locked to a stimulus with a pretrigger.
SSEP provides two types of measurements, i.e. amplitude and latency (figure 1.7). Amplitude is
defined as the maximum extent of a vibration or oscillation, measured from the lowest point to
the highest point. Latency is defined as the delay before the actual SSEP waveform is detected by
the receiver electrode. The normal range of latency and amplitude is reported to be 15.0-16.0 ms
and 1.0-2.0 microvolt, respectively2, 22, 23.
Also, SSEP has an embedded filter that removes all the other signals that have different
amplitudes, such as ECG signals (i.e. SSEP has an amplitude of approximately 1 microvolt while
ECG has an amplitude of approximately 1 millivolt). It is the gated, repetitive (300/min; 5 Hz)
summation of individual SSEP signals that enables the very low amplitude SSEP nerve
conduction impulse to be extracted by filtering the electrical ‘noise’ from other sources including
myocardial depolarization and 60Hz electrical interference. Stimulation electrodes are placed
over the course of the desired nerve, with the cathode placed 2 cm proximal to the anode. Skin at
the scalp EEG electrodes should have an impedance lower than 5,000 ohms. Clinically, the
amplitude and latency are obtained from each SSEP signal, and because of its high reliability,
SSEP is frequently used in the OR in patients undergoing spinal cord surgery and surgery for
scoliosis. Nerve injury commonly results from stretch or direct damage to the nerve. It results in
the prolongation of latency and/or reduction of amplitude of SSEP signals. According to one
study32, the sensitivity and specificity of SSEP monitoring in detecting nerve injury
intraoperatively was reported to be 95% and 100%, respectively, when a cut-off of either 50%
reduction in amplitude or 10% prolongation of latency was used. Also, it has been reported that
SSEP monitoring has resulted in a 50–60% decrease in postoperative paraplegia in the scoliosis
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surgery30.

Figure 1. 7 Amplitude and latency

In order to investigate the incidence of PNIs in two types of cardiac surgeries, we designed this
observational study using a portable SSEP device (EPAD ®). Conventional SSEP monitoring
requires a dedicated technician and equipment. The total cost of this monitoring ranges from
$600 to $8503. Recently, an automated SSEP device, EPAD®, which incorporates an automated
algorithm for signal activation, acquisition, optimization and interpretation, was developed and
proved to be useful in cardiac surgery2. In the current study, the electrodes are placed bilaterally
on the median and ulnar nerves (figure 1.8, stimulating electrodes), midline on the fifth cervical
spine (figure 1.8, receiving electrode) and midline on the forehead (figure 1.8, reference
electrode). EPAD® has the ability to automatically detect baseline SSEP amplitude and latency,
and produce SSEP signals at 300 waveforms per minute. This device automatically records
baseline values as well as intraoperative SSEP waveforms, and its usefulness has been confirmed
by some reports2. Also, EPAD® automatically generates all the impedance values at the
electrode attachment sites. The clinical feasibility of the EPAD® may reduce the need for
expensive SSEP monitoring and allow for routine monitoring during cardiac surgery by the
anesthetic provider.
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Reference electrode

C5 receiving electrode

Stimulating electrodes
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Figure 1. 8 SSEP signals obtained on an EPAD.
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1.7 Primary Objectives
This paper aims to comparatively analyze the cumulative duration of intraoperative abnormal
SSEP signals, the average of all monitored nerves (a surrogate marker of nerve injury) between
MICS and CCS. MICS includes robotic CABG surgery and TAVI, while CCS includes open
CABG and open AVR. Abnormal SSEP is defined as a 50% reduction in amplitude and/or a
10% prolongation of latency32.

1.8 Secondary Objectives
1. Sensitivity and specificity of EPAD® device to detect clinically symptomatic participants
2. To report the relationship between several factors (DM, renal dysfunction, hypertension, and
preexisting neuropathy) and abnormal SSEP/neuropathy.
3. to investigate the relationship between PNI detected through SSEP and the intraoperative
events, such as sternotomy, the initiation of CPB and ITA harvest.

1.9 Rationale and Hypothesis
As mentioned in the introduction, PNIs related to surgery can lead to significant medico-legal
issues as well as functional inconvenience to patients, and a great deal of research has been done
in this field in general surgery and CCS. However, no data exists regarding PNIs in MICS. Since
MICS does not require sternotomy, sternal retraction and CPB, we hypothesized that the degree
of nerve injury is less in MICS compared with CCS. In this study, we will look at the incidence
of PNIs in MICS compared to CCS using a surrogate marker, i.e. abnormal SSEP signals as an
indication of intraoperative nerve injury (primary outcome). Also, the relationship between
intraoperative nerve injuries detected through SSEP and the intraoperative events, such as
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sternotomy, the initiation of CPB and ITA harvest, has not been researched. Newly developed
MICS can be used as a control for comparison to sternotomy and the use of CPB. In this study,
we will investigate the correlation of intraoperative abnormal SSEP signals and intraoperative
events (secondary outcome). Lastly, we will perform multiple regression analysis to investigate
the relationship between several predisposing factors and the intraoperative PNI (secondary
outcome).
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2 Methodology
2.1 Study Design
This is a single-center, prospective observational cohort study with a planned enrollment of 100
adult cardiac surgery patients, investigating the association between type of cardiac surgery and
intraoperative nerve injury. The study participants, who underwent either CCS or MICS were
monitored by an automated SSEP device (EPAD®) to quantify the burden of intraoperative
peripheral nerve injury (primary outcome) and were followed up in the postoperative period to
identify clinically apparent new-onset neurological injury (secondary outcomes).

2.2 Setting
The study was conducted at University Hospital, London Health Sciences Centre, which has
approximately 1400 cardiac surgery cases annually. Recruitment started in November 2017 and
was undertaken by the principal investigator. I obtained approval from the Western University
Health Science Research Ethics Board. The trial was registered into the public domain on
clinicaltrials.gov (NCT#03422107).

2.3 Participants
2.3.1 Recruitment
The day before surgery, the operating room scheduling list is reviewed, and potential study
candidates are screened. Recruitment takes place in the surgical preparation room adjacent to the
operating room prior to surgery. The participants who meet the eligibility criteria were
approached and consented.
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2.3.2 Inclusion and Exclusion Criteria
All patients 18–90 years of age undergoing cardiac surgery were included in this study. The
exclusion criteria include any contraindication to SSEP monitoring, which includes skin burns or
trauma at SSEP electrode sites (due to inability to place the electrodes), lack of written consent,
emergency surgery, language barriers, fluctuating neurological symptoms, the utilization of
regional anesthesia (spinal, epidural, nerve block), CABG with radial artery harvest, and
combined surgeries, such as CABG plus valve surgery.

2.4 Study Procedures
Patients were assigned to one of two surgical groups dependent on the use of midline sternotomy
(CCS) or incision on the chest wall with no sternotomy (MICS). No attempt was made to balance
the groups with regard to DM, BMI, surgeons or other confounders.

2.4.1 Informed Consent
Informed consent was obtained from each participant in the surgical preparation area prior to
entering the operating room. It was explained to the participants that the current study is an
observational study and no action would be taken when abnormal SSEP signals were detected
intraoperatively. Signed original consent forms were kept in a locked room in a secure facility at
University Hospital, London, Ontario.
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2.4.2 Preoperative Data Collection
After obtaining written informed consent, a brief bilateral upper-limb motor and sensory
neurological examination was performed in the surgical preparation area as follows. Firstly,
participant’s baseline characteristics including a past medical history of: hypertension, diabetes
mellitus, end-stage renal dysfunction and pre-existing neuropathy, was obtained from the
participant or the electronic chart. Pre-existing neuropathy here is defined as the presence of
symptoms at interview, such as tingling and/or numbness in the hands. End-stage renal
dysfunction is defined as dialysis dependent renal failure. Following this preoperative
assessment, the examiner performs a cold sensation test using a bag of ice placed on the median
and the ulnar nerve areas bilaterally. For this test, the area above the clavicle is used as a
reference point. If the participant is unable to feel the cold as much as the reference point, it is
described as partial loss, and if the cold sensation is completely lost, it is described as absent.
Finally, motor function was assessed using manual muscle testing on a scale of 0 – 5 (See
appendix). 5 = normal strength, 4 = mild weakness (weakly or briefly able to overcome examiner
resistance), 3 = able to support the limb against resistance but unable to overcome examiner
resistance, 2 = can move the limb, but unable to lift against gravity, 1 = flicker but no movement,
and 0 = no movement. The motor function of the ulnar nerve is assessed by asking the participant
to adduct the thumb and flex the hand, that of the median nerve is assessed by asking the
participant to flex the hand, abduct and oppose the thumb. The motor function of the radial nerve
is assessed by asking the participant to extend the hand and the fingers.

All the patients received adequate padding at the elbows to protect ulnar nerves and meticulous
attention was paid to the arm positioning prior to surgery by the attending anesthesiologists as
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well as nursing staff. Standard padding in the OR includes soft pads, sponges or towels placed on
the vulnerable anatomical structures, such as the elbow, arm, hand, and shoulder. CABG, AVR
and TAVI were performed in the supine position and robotic CABG was performed in the 3045°lateral position.
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2.4.3 Intraoperative Data Collection

Variables

Definition

Type of variables

Source of information

Diabetes Mellitus

Taking oral medication or Insulin

Dichotomous variables

Participant’s chart

(yes or no)
Hypertension

Taking oral medication

Dichotomous variables

Participant’s chart

(yes or no)
End stage renal dysfunction

Dialysis dependent

Dichotomous variables

Participant’s chart

(yes or no)
Pre-existing neuropathy

Duration of surgery

Use of CPB

Tingling/numbness or motor

Dichotomous variables

Preoperative

dysfunction at baseline

(yes or no)

neurological assessment

Time from skin incision to skin

Continuous variables

Participant’s chart

closure

(minutes)

Cardiopulmonary bypass used

Dichotomous variables

during surgery

(yes or no)

Participant’s chart

Table 2 Summary of relevant variables collected intraoperatively

Stimulator electrodes were put on the bilateral median and ulnar nerves, and receiver electrodes
were placed on the back of the neck (fifth cervical spine level, C5). During central line insertion,
baseline SSEP values are obtained. The data monitored during the study include the amplitude
and latency. In the current study, all the artifacts are included in the final analyses because
artifacts are difficult to identify, and inconsistently observed both in CCS group and MICS
group. All the data collected were recorded on the paper data collection sheets and in Redcap.
Due to the observational nature of this study, no actions, i.e. change the participant’s positioning
or modification in surgical techniques, were taken when abnormal SSEP signals were observed.
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2.4.3.1 The Cumulative Duration of Abnormal SSEP Signals
This is the primary outcome. Abnormal SSEP signals are defined as at least 50% reduction in
amplitude and/or 10% prolongation in latency. The EPAD® device has an auto-analysis
algorithm that detects these abnormalities and generates a detailed report including the raw data
and processed data, such as baseline SSEP amplitude and latency. The total duration of abnormal
SSEP signals is the sum of all the durations when abnormal SSEP signals are observed. All the
calculations are performed on Microsoft Excel using a consistent calculation method to avoid
measurement error.

2.4.3.2 Timing of Abnormal SSEP Signals
The principal investigator remains in the operating room and tracks intraoperative events, such as
sternal retraction for ITA harvest and the initiation and termination of CPB in CABG and AVR,
valve deployment in TAVI and ITA harvest in Robotic CABG. This is recorded and subsequently
integrated into the SSEP data.

2.4.4 Postoperative Data Collection
Follow-up occurred from day 0 to day 5 and consisted of the same neurological exam performed
preoperatively including sensory and motor testing, where possible, the assessor was blinded to
the intraoperative SSEP results. Positive PNI findings were documented and also communicated
to the surgical team for further follow-up.
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2.5 Sample Size
2.5.1 Primary Outcome
The duration of abnormal SSEP signals, the average of all the monitored nerves, is the primary
outcome in the current study. We performed a sample size calculation using data obtained from
our pilot study. We used a mean of 40 minutes duration of abnormal SSEP signals with a
standard deviation of 20 minutes. With the α = 0.05, Power (1-β) = 0.9, and an allocation ratio =
1:1. Figure 2 below shows that sample size of 100 and a mean difference of 15 minutes between
the two groups would provide 95% power to detect a difference.

STATA command: power twomeans 40 (10 (1) 30), sd(20) n(100) graph

Figure 2 The result of power analysis performed on STATA
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2.5.2 Secondary Outcomes
Secondary outcome 1, sensitivity and specificity of EPAD® to detect PNI is calculated using a
2x2 table. Sensitivity = TP/TP+FN, Specificity = TN/TN+FP, where TP: true positive, FN: false
negative, TN: true negative, FP: false positive. True positive is defined as participants who have
clinical symptoms of PNI and intraoperative abnormal SSEP signals. False negative is defined as
participants who have clinical symptoms but do not have intraoperative abnormal SSEP signals.
True negative is defined as participants who do not have clinical symptoms of PNI and do not
have intraoperative abnormal SSEP signals. False positive is defined as participants who do not
have clinical symptoms but do have intraoperative abnormal SSEP signals. 2. To report the
relationship between several factors (DM, renal dysfunction, hypertension, and preexisting
neuropathy) and abnormal SSEP/neuropathy. Therefore, this will be analyzed with multiple
regression analysis.

2.6 Statistical Analysis
The demographics include age, gender, height, weight, Body Mass Index (BMI), type of
procedure, the presence of hypertension, diabetes, history of stroke, history of end stage renal
disease, history of pre-existing neuropathy, duration of surgery and duration of CPB. Continuous
variables are analyzed using either student’s t-test if the variable has a normal distribution or
Mann-Whitney U test if the variable does not have normal distribution. Dichotomous variables
are analyzed using Chi-square test or Fisher’s exact test.

Intraoperative nerve injury is defined as the presence of abnormal SSEP signals during surgery.
Postoperative neuropathy is defined as newly developed neuropathy and/or exacerbation of the
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pre-existing neuropathy compared to baseline.

The primary outcome, the cumulative duration of abnormal SSEP signals, the average of all
monitored nerves, was analyzed using Student’s t-test if the variable has a normal distribution or
Mann-Whitney U test if not. When the SSEP data is not obtained from all 4 nerves, the average
of 1,2, or 3 nerves are calculated depending on the number of nerves which provided
interpretable data. When a significant difference is observed in baseline characteristics, the
primary outcome is adjusted using linear regression analysis.

The secondary outcome will be analyzed using multiple regression analysis. The independent
variable is the cumulative duration of abnormal SSEP signals, the average of all monitored
nerves. The dependent variables include diabetes, pre-existing PNI, end stage renal failure
and hypertension.
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3 Results
All the tables and figures in this chapter will be presented at the end of Chapter 4 for clarity.

3.1 Participants
Over the 6 months period, 51 participants were screened using the operating room scheduling
lists. Fifty-one participants were approached and consented to participate in the study (Figure
3.1). Out of the 51 participants, 41 participants provided intraoperative SSEP data while 10
participants failed to do so because of technical problems with the EPAD® device. 47
participants received postoperative neurological assessments, and 6 of them demonstrated
symptoms of peripheral nerve injury. Four participants were discharged at the time of scheduled
postoperative neurological assessments and failed to complete the assessments. A total of 41
participants provided complete or partial SSEP data; 36 participants provided SSEP signals from
all four nerves (39 participants provided SSEP signals from left ulnar, 40 provided right ulnar, 38
provided left median and 38 provided right median). In 10 participants, complete data sets were
not obtained due to technical problems of EPAD® device. The most commonly encountered
technical problems associated with SSEP data collection was detachment of C5 electrode. Other
problems included displacement of other electrodes, issues with data transfer and hardware
problems.
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3.2 Demographics
Baseline characteristics are comparable between the two groups with regard to gender, height,
weight, BMI, rates of hypertension, diabetes, history of stroke, history of end stage renal disease,
history of pre-existing neuropathy (Table 3.1). There is a statistically significant difference
between the two groups in age, and participants in MICS group are significantly older than those
in the CCS group. With regards to co-morbidities, 28 participants had a history of hypertension,
16 diabetes, 1 non-debilitating stroke, 1 end-stage renal disease and 6 pre-existing neuropathies.
In the current study, there are no statistically significant differences in the rates of co-morbidities.
A statistically significant difference between the two groups was noted in the duration of surgery,
the CCS group had a longer duration of surgery compared with MICS group (230±48 v.s. 116±
39 minutes, P<0.001).

Twenty-two participants in CCS group provided baseline SSEP data while 19 participants did in
the MICS group (Table 3.2). At baseline, CCS and MICS groups demonstrated SSEP latencies
and amplitudes within normal limits except for the right median nerve. The latency of the right
median nerve is statistically significantly longer in CCS group compared with MICS group.
Other than that, no statistically significant differences were observed between the two groups
with regard to amplitude and latency.
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3.3 Outcome Data
All four nerves were equally affected in the two groups. In the CCS group, 6 of 14 patients
(44%) who underwent CABG had abnormal SSEP signals during ITA harvest. Overall, the
abnormal SSEP signals were observed independently of the intraoperative events. In the MICS
group, abnormal SSEP signals were observed throughout the surgeries independent of
intraoperative events.
Six out of 47 participants (4 participants did not complete postoperative neurological
assessments) developed postoperative neuropathy. Four participants had their left hand affected,
one had their right hand affected and one was affected bilaterally. Three out of 6 participants had
a complete set of SSEP data, and the other 3 participants had some or all the data missing
because of technical problems. Among the 6 participants who showed symptoms of PNI, 4
participants underwent CABG, 1 had AVR, and the other 1 had TAVI. Only 1 participant
undergoing CABG had motor dysfunction (left sided motor dysfunction, strength of 2 on a scale
of 0-5 in the radial region) while none of the other participants had motor deficit symptoms. One
participant undergoing AVR had tingling/numbness in the right radial nerve distribution. Two
participant undergoing CABG had left sided numbness/tingling in the ulnar nerve distribution.
Another participant undergoing CABG had bilateral numbness in the finger tips. The one
participant undergoing TAVI had left sided loss of sensation in the radial nerve distribution.
Overall, in the current study, CABG surgery is associated with the highest incidence of PNI after
surgery based on postoperative neurological assessments, and there is a tendency for left side to
be affected more frequently compared to the right side. The affected modality was predominantly
sensory (Table 3.4)
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3.4 Main Results
3.4.1 Primary Analysis
Data are described as mean±SD.
Using the unadjusted data, the average of the cumulative duration of abnormal SSEP signals was
higher in CCS group compared to MICS group (1657±2253 seconds vs. 472±481 seconds, P =
0.031, Figure 4.3); the left ulnar nerve was higher in CCS group compared to MICS group (1842
±2560 seconds vs. 333±753 seconds, P = 0.017); the left median nerve was higher in CCS
group compared to MICS group (2713±5400 seconds vs. 25±56 seconds, P = 0.027); the right
ulnar nerve did not show any statistically significant difference 1626±3034 seconds vs. 1180±
1529 seconds, P = 0.575); the right median nerve did not show any statistically significant
difference (682±1354 seconds vs. 360±706 seconds, P = 0.372).
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3.4.2 Secondary Analysis
Table 3. 6 Two by two table for EPAD® in the current study.
Table 3.6 is on page 68. The sensitivity and specificity of EPAD® to detect clinically
symptomatic patients is 100% and 11%, respectively.

3.4.2.1 To report the relationship between several factors (DM, renal
dysfunction, hypertension, and preexisting neuropathy) and abnormal
SSEP/neuropathy.
A univariate multiple regression was run to predict the primary outcome (cumulative duration of
abnormal SSEP signals, the average of all monitored nerves) from age, type of surgery (MICS vs
CCS), Diabetes, hypertension, Pre-existing neuropathy, end stage renal failure, duration of
surgery. Firstly, F-test of overall significance indicates whether this multiple linear regression
model provides a better fit to the data than a model without independent variables. Since P<0.05
(table 3.7), the null hypothesis that the model with no independent variables fits the data as well
as our model is rejected. Secondly, R2=0.428 means our independent variables predict 42.8% of
the variability of our dependent variable. Lastly, the general form of the equation to predict the
primary outcome is as follows:
Cumulative average duration of abnormal SSEP signals= -5760+(46×age) +
(1388×hypertension) - (211 ×diabetes mellitus) + (561×pre-existing neuropathy) + (1351×endstage renal failure) - (290×type of surgery). Only the duration of surgery has the statistically
significant positive relationship with the primary outcome, P=0.017.
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3.4.2.2 The Relations between Surgical Procedures/CPB and SSEP Timing
The association between the intraoperative events and the abnormal SSEP signals was recorded.
The abnormal SSEP signals were detected independent of intraoperative events in the two
groups. Overall, 91% and 89% of participants showed abnormal SSEP signals during surgery in
CCS and MICS groups, respectively. In the CCS group, 73% of the participants had abnormal
SSEP signals before the initiation of CPB, and 91% of the patients had abnormal SSEP signals
during or after the initiation of CPB. Specifically, no effect on SSEP signal was seen during
sternal retraction, ITA harvest or during CPB. In TAVI, there was no association between the
abnormal SSEP signals and the timing of valve deployment. In Robotic CABG, the abnormal
SSEP signals were seen regardless of intraoperative events, such as ITA harvest. (Table 3.3)
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4 General Conclusion
In this study, I demonstrated that patients undergoing CCS are exposed to more nerve injuries
compared to those undergoing MICS.

4.1 Discussion
Previous studies have shown that sternotomy and the retraction of the sternum are responsible for
higher incidence of PNI in cardiac surgery3 compared to non-cardiac surgery11, and the results of
the current study are consistent with the previous reports in a sense that surgeries that require
sternotomy and its retraction have higher rates of PNI compared to surgeries that do not require
those. However, our current study shows that abnormal SSEP signals are observed independently
of intraoperative events, such as sternotomy, its retraction or the initiation of CPB. Also, I found
that only 44% of the patients who underwent CABG had abnormal SSEP signals during ITA
harvest. This is in contrast to previous studies with have demonstrated that sternal retraction for
ITA harvest plays a significant role in the etiology of PNIs in CABG

Regarding the relationship between risk factors and abnormal SSEP signals, the current study is
unable to detect statistically significant risk factors other than the duration of surgery probably
because of its small sample size.

Interestingly, the vast majority of patients who had abnormal SSEP signals during surgery did
not display any clinically apparent postoperative symptoms. The presence of false positives, i.e.
participants who had abnormal SSEP signals without clinical PNI symptoms, might suggest that
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mere nerve damage is not enough to cause clinical symptoms; rather, additional insults are
required for symptoms to manifest. Another possibility is that the clinical usability of the
EPAD® device has been reported in previous studies2, however, sensitivity and specificity of this
device has never been investigated. Based on the results of the current study, the EPAD® device
may be more sensitive than conventional SSEP devices. As a result, it is possible that this device
has a low specificity, and further studies are warranted to investigate its usefulness for its daily
use in the operating room. At least, a certain level of specificity is required for clinicians to make
a diagnosis and determine treatment options based on this monitoring tool. In the current study,
sensitivity and specificity were 100% and 11%, respectively. The built-in automated artifact filter
of the EPAD® device may have overlooked significant amounts of artifacts. Since EPAD® is a
newly developed device, the accuracy of the automated filter has not been investigated fully.
Again, further investigations are warranted to scrutinize this device in the clinical setting.

Four out of 6 participants who had postoperative symptomatic PNI underwent CABG surgery.
Mechanical injuries, such as sternal retraction and subsequent traction of the brachial plexus, are
thought to play a major role in the etiology of PNI in this surgery. However, in the current study,
abnormal SSEP signals were observed throughout this surgical procedure, independent of sternal
retraction. This implies that injury afflicted by sternal retraction was further compounded by the
systemic inflammation possibly caused by the use of CPB or the pre-existing susceptibility, such
as DM, and the combination of at least these events/risk factors might have led to the
manifestation of PNI symptoms in the vulnerable population. Some pre-existing co-morbidities
are more prevalent in some groups, i.e. CABG and AVR have more diabetic patients compared to
Robotic CABG and TAVI because of systemic atherosclerosis. This is one of the confounding
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factors in this study. Further observational studies using a larger sample size is warranted to
clarify exactly what types of predisposing factors contribute to the manifestation of postoperative
PNI symptoms.

In the current study, no statistically significant differences were observed between the two
groups with regard to amplitude and latency at baseline. This is important because baseline SSEP
signals provide information regarding pre-existing clinical or subclinical nerve injury. In the
current study, the baseline SSEP signals were comparable except for the right median nerve. This
indicates that the rates of patients with pre-existing nerve function were similar between the two
groups. In TAVI, the cardiologist places a sheath introducer in the right radial artery, so the
SSEP electrode for right median nerve was placed a few inches higher compared to other types
of surgeries in the current study. This might have resulted in the statistically significant
difference in latency of the right median nerve between the two groups.

Previous studies on PNIs in cardiac surgery have been inconsistent in terms of incidence and
mechanisms possibly due to the following reasons. Firstly, most patients underreport their PNI
symptoms on immediate postoperative days. Therefore, detailed history taking and neurological
assessments are required to capture PNI symptoms post cardiac surgery before symptoms resolve
spontaneously. This phenomenon was observed in the current study as well, and all the
participants who had PNIs after cardiac surgery did not inform their surgeons about their
symptoms. Some participants did not even notice their symptoms and only realized them when
pertinent questions were asked or neurological examinations were conducted. In the current
study, we assessed participants on POD 0-5 in order not to miss PNI in the immediate
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postoperative setting. Secondly, previous studies on cardiac surgery have non-expert assessors,
such as ICU nurses or nonmedical research assistants, perform neurological examinations or wait
for the participants to complain of their PNI symptoms.5 It is highly likely that non-experts may
have missed some cases of PNI.

4.2 Clinical Relevance
An increasing number of centers have recently started to perform MICS. This trend is based on
literature that reported the noninferiority of minimally invasive surgery in terms of patient
prognosis and the absence of recurrence of the original pathologies. MICS is associated with
early recovery and shorter hospital stay compared to CCS. It has been known that CCS has a PNI
incidence of around 15%; for MICS, no research has been conducted regarding the incidence of
PNI. The current study is the first to investigate PNI incidence in MICS in terms of abnormal
SSEP signals compared with CCS. Although this study is underpowered to compare the
incidence of clinically apparent postoperative PNI symptoms, our results have demonstrated
significant differences in incidences of PNI between CCS and MICS using a surrogate marker,
that is, abnormal SSEP signals. When multiple linear regression was run, no significant
difference was observed between the two groups in any of the independent variables except for
the duration of surgery. However, under normal circumstances, MICS has shorter duration of
surgery compared to CCS. Since the short duration of surgery is one of the advantages of MICS,
it would be reasonable to say that MICS is associated with less nerve injury as a whole. In
addition, it is possible that the current study is significantly underpowered to detect risk factors
for postoperative PNI. Another power analysis needs to be performed to calculate sample size for
this outcome in the future trials.
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Also, this study demonstrated that intraoperative PNI occurred throughout the surgery
independent of sternal retraction or the initiation of CPB. This is in contrast to previous studies
that PNIs in cardiac surgery are caused mainly by mechanical injuries during sternotomy and
sternal retraction. The current study suggests that the combination of multiple factors might have
played a role in the etiology of PNIs in cardiac surgery. These factors include sternal retraction,
patients’ co-morbidities, such as diabetes and pre-existing neuropathy, and the use of CPB, which
triggers systemic inflammation that results from the use of foreign body and non-pulsatile blood
flow33-38. MICS group does not have CPB nor sternal retraction, and this may account for less
PNI in MICS groups compared to CCS group. Our findings might add more clinical value to the
indication of MICS in a selected patient population.

4.3 Strengths of the Study
We performed both preoperative and postoperative neurological assessments. Many previously
published studies failed to identify an exacerbation of a preexisting neuropathy because they did
not perform preoperative neurological assessments7, 14. In the current study, the principal
investigator assessed participants’ neurological status prior to surgery which permitted the
detection of pre-existing PNI. Also, most published studies did not perform postoperative
neurological assessments immediately after surgery14, 16. Since the majority of patients with PNI
spontaneously resolve with time, a large number of cases might have been missed in those
studies. In our study, the assessor approached participants within 5 days after surgery and
performed postoperative neurological assessments to capture symptoms of PNI before they
resolved spontaneously.
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Another advantage of the current study is that the assessors are certified anesthesiologists who
have sufficient training and ability to assess patients’ neurological symptoms. Also, assessors
who performed postoperative neurological examinations were all blinded to the intraoperative
SSEP data.

4.4 Limitations of the Study
There are a few limitations to this study.
1. No postoperative SSEP monitoring in the ICU was conducted. It has been known that
symptoms of PNI become apparent a few days or hours after surgery. This means that we
might have missed onset of PNI that manifested after our postoperative neurological
assessments.

2. The surrogate marker SSEP was used in our study instead of clinically apparent PNI, which
have given the incidence of 15%, would render the study significantly underpowered to
detect differences. In addition, according to one study,4 the sensitivity and specificity of
SSEP in detecting nerve injury was 95% and 100%, respectively, when the cut-off of either
50% reduction in amplitude or 10% prolongation of latency was used. This result was used to
justify the use of SSEP monitoring, as a surrogate for PNI, in the current study. The
sensitivity and specificity of EPAD® device has not been fully investigated, being a
relatively new device. The results of the current study suggest that this assumption may not
be valid.
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3. In this study, a couple of patients had radial neuropathy after cardiac surgery. Since our
device was not capable of monitoring the radial nerve (only 4 channels), intraoperative
insults specifically to the radial nerve were not captured. We included radial nerve
neuropathy in the postoperative assessments because we assumed that the average
cumulative duration of all the monitored nerve would reflect the total amount of nerve
insults. Also, all the participants in the current study received an arterial line in the radial
artery and all the participants undergoing TAVI received a sheath introducer on the other arm.
According to the latest report19, the rate of radial nerve injury after radial arterial line
insertion is 0.03%. Although this incidence is low, we could not rule out arterial line insertion
as a cause for PNI of the radial nerve in the current study.

4. In the cardiac OR, various types of SSEP signal interference were present, such as electric
cautery, surgeons leaning on the patient, temporary/permanent pacemakers, and manipulation
of the transesophageal echocardiogram (TEE) probe. The use of EPAD® device in shoulder
surgery has been validated39, however, the current study suggests that it may be challenging
in cardiac OR. Although EPAD has an embedded artifact filter, it is not capable of removing
all artifacts. The EPAD® device may be more susceptible to artifacts compared to
conventional SSEP devices because all the electrodes use adhesive pads in the EPAD®
device compared to needle electrodes used in conventional SSEP monitors.

5. I set our target recruitment at 100, however, I was unable to reach this number for the
following reasons. Firstly, this study was conducted by a single principal investigator (SF)
within a period of 1 year. Because of paucity of access to dedicated research time, I was able
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to recruit 1-2 patient per week on average. As a result, the target number was not met during
this study period.

4.5 Bias
Selection bias occurs during identification of the study population. When a study population is
identified, selection bias takes place when the criteria used to recruit and enroll patients into
separate study cohorts are inherently different. In the current study, this bias is minimized
because this is an observational study and outcome variables are unknown at the time of
recruitment.

Interviewer bias is caused by variations in the way different interviewers collect information
from participants. In the current study, this bias is minimized in the following way. Only the
principal investigator performs pre-study interview and preoperative neurological assessments.
For postoperative neurological assessments, the number of interviewers is limited. Throughout
the assessment process, interviewers utilize the standardized Redcap data collection sheet for
their assessment criteria to be consistent.

Outcome misclassification bias results when poorly defined outcomes are used in the analyses.
The effort to minimize outcome misclassification bias includes the use of an objective and
validated variable as the primary outcome, and we clearly defined all the outcomes in our
protocol. In the current study, all the variables used for our analyses are clearly defined in our
protocol.
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Confounding occurs when there is a factor that is independently associated with both the
outcome of interest and the exposure. Multiple regression analysis is performed to control for
identified confounders. However, unidentified confounders are not controlled due to the
observational nature of this study.

4.6 Technical Difficulties
In this study, we encountered quite a few technical difficulties with the EPAD device:

1. As reported by Chui et al.,13 equipment failure frequently occurred at the beginning of the
study mainly because of poor contact or displacement of the C5 cervical electrode. Since this
is the only receiving electrode, it is not possible to proceed with the study without a
functioning C5 electrode. The solution to this problem is to place a new electrode or carefully
prepare the skin for better adhesion.

2. During TAVI, cardiologists use the right radial artery for the arterial catheter. This practice
made it impossible to put electrodes on the wrist, so we placed the electrodes a few inches
higher from the catheter.

3. Various types of artifacts appeared on the screen.
A. Figure 4.1 shows an interference artifact caused by a certain type of pacemaker.
According to the manufacturer, EPAD® has the ability to remove artifacts generated by
most of the pacemakers, but new pacemakers are not registered yet and can cause
artifacts.
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Figure 4. 1. Interference artifact.

B. This artifact (Figure 4.2) was due to poor attachment of the receiving electrode with the
skin. One solution is to prepare the skin with abrasive or lubricant before placing the
electrode.

Figure 4. 2. Poor attachment artifact.

C. When the C5 electrode is displaced, all the waveforms disappear from the screen (Figure
4.3). The solution is to replace the electrode.
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Figure 4. 3. No waveforms due to complete electrode detachment.

D. Every time a problem occurs with the device, the data needed to be deleted from the
tablet. Otherwise, the message below would appear, and the tablet would stop working.

Figure 4. 4. An error message that appears when the damaged data is stored.
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4.7 Final Remarks and Further Direction
Given the findings of this single center study, the sensitivity and specificity of the EPAD®
device needs to be investigated in a larger more diverse patient population. This may include
studies as comparing EPAD® to conventional SSEP devices as the results of the current study
suggest that the sensitivity of EPAD® device is high but the specificity is low possibly because
of the captured artifacts.

Further observational studies are needed to identify the exact mechanisms of PNI in cardiac
surgery. Future studies should investigate only patients at increase risk, such as those with
diabetes, pre-existing neuropathy, or renal dysfunction. With a larger sample size, the primary
outcome should be powered to examine the clinical outcome of interest, PNI and its risk factors.
The current study clarified that the majority of patients get nerve insults during cardiac surgery,
but not all who have abnormal SSEP signals, as measured by the EPAD® device suffer from
symptoms of PNI. With an appropriate study design, we will be one step closer to clarifying the
mechanisms of PNI in cardiac surgery.
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Tables and Figures of Chapter 3

Figure 3. 1 Study participant flowchart for the current study.
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CCS (n = 22)

MICS (n = 19)

P

Age, y

68 ± 10

82 ± 6.8

<.0001

Female, n

6

8

0.346

Height, cm

173 ± 11

166 ± 10

0.057

Weight, kg

84 ± 17

83 ± 14

0.968

BMI, m/kg2

28 ± 4

30 ± 5

0.101

Patient characteristics

Type of procedure, n
Coronary bypass grafting

14

0

Aortic valve replacement

8

0

TAVI

0

15

Robotic coronary bypass

0

4

Hypertension, n

12

16

0.052

Diabetes, n

7

9

0.352

History of stroke, n

1

0

1.000

1

0

3

3

Duration of surgery, min

230 ± 48

116 ± 39

<.0001

Duration of CPB, min

93 ± 33

NA

NA

grafting

History of end stage renal

1.000

disease, n
History of pre-existing

1.000

neuropathy, n

Values are expressed as number (percentage) or mean ± SD when appropriate.
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NA. Not Applicable; NS. Not Significant

Table 3. 1 Patient Characteristics.
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CCS (n=22)

MICS (n=19)

P

Left ulnar

1.4 ± 0.4

1.3 ± 0.5

0.675

Right ulnar

1.2 ± 0.6

1.2 ± 0.6

0.792

Left median

1.6 ± 0.6

1.4 ± 0.5

0.295

Amplitude (microV)

Right median

1.6 ± 0.7

1.4 ± 0.6

0.399

Left ulnar

15.9 ± 1.9

16.0 ± 1.1

0.811

Right ulnar

16.2 ± 1.9

14.9 ± 3.0

0.098

15.9 ± 1.4

0.472

13.6 ± 4.0

0.024

Latency (ms)
Left median
Right median

15.4 ± 1.9
15.9 ± 1.6

Table 3. 2 Amplitude and Latency at baseline in CCS and MICS groups.

52

CABG (n=14)
Before ITA harvest

During ITA harvest

During/after CPB

% (n)

% (n)

% (n)

Left ulnar nerve

23 (3)

15 (2)

69 (9)

Left median nerve

17 (2)

17 (2)

42 (5)

Right ulnar nerve

36 (5)

29 (4)

79 (11)

Right median nerve

42 (5)

17 (2)

58 (7)

Before CPB

During/after CPB

% (n)

% (n)

Left ulnar nerve

25 (2)

38 (3)

Left median nerve

25 (2)

13 (1)

Right ulnar nerve

38 (3)

87 (7)

Right median nerve

25 (2)

38 (3)

AVR (n=8)
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TAVI (n=15)
Before valve

During/after valve

deployment

deployment

% (n)

% (n)

Left ulnar nerve

38 (5)

31 (4)

Left median nerve

23 (3)

8 (1)

Right ulnar nerve

69 (9)

62 (8)

Right median nerve

50 (7)

36 (5)

Before ITA harvest

During/after ITA

% (n)

harvest

Robotic CABG (n=4)

% (n)
Left ulnar nerve

0 (0)

50 (2)

Left median nerve

0 (0)

0 (0)
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Right ulnar nerve

0 (0)

75 (3)

Right median nerve

0 (0)

0 (0)

Table 3. 3 Timing of abnormal SSEP signals
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Type of surgery

1

AVR

Type of neuropathy

Right radial

Date of assessment (POD)

Age

HTN

DM

PEN

3

71

_

_

_

tingling/numbness
2

CABG

Left ulnar numbness

4

66

+

_

_

3

CABG

Bilateral numbness in

3

77

_

_

_

finger tips
4

CABG

Left radial motor palsy

3

72

+

+

_

5

CABG

Left ulnar tinglings

2

79

+

_

_

6

TAVI

Left radial loss of

1

86

+

_

_

sensation
POD. Post operative day; DM. Diabetes mellitus; HTN. Hypertension; PEN. Pre-existing neuropathy

Table 3. 4 Breakdown of all six patients who had clinically apparent symptoms of PNIs after
surgery
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Cumulative duration of abnormal SSEP

P
CCS (n=22)

MICS (n=19)

1657±2253

473±481

0.031

signals
Average of all monitored nerves, (sec)
•

Left ulnar nerve, (sec)

1843±2560

333±753

0.017

•

Right ulnar nerve, (sec)

1625±3034

1180±1529

0.575

•

Left median nerve, (sec)

2713±5400

25±56

0.038

•

Right median nerve, (sec)

682±1354

360±706

0.372

Table 3. 5 Cumulative duration of abnormal SSEP signals. Left ulnar, right ulnar, left median,
right median, and the average of all monitored nerves, unadjusted data.
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Figure 3. 2 Cumulative duration of abnormal SSEP signals, the average of all monitored nerves,
using unadjusted data.

(N)

PNI

Abnormal SSEP signals observed

No abnormal SSEP signals observed

3

0

32

4

symptoms
No PNI
symptoms
Table 3. 6 Two by two table for EPAD® in the current study.
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df

F

P

Regression

7

3.526

.006

Residual

33
R

R squared

Adjusted R Squared

0.654

0.428

0.307

Model

Variables

Coefficients
P value
(95% Confidence Interval)

Type of surgery
-290 (-1869, 1289)

0.711

-211 (-1346, 925)

0.708

561 (-828, 1951)

0.417

1351 (-2050, 4754)

0.425

1388 (-91, 2867)

0.065

46 (-33, 125)

0.242

16 (3, 29)

0.017

(MICS vs CCS)
Diabetes

Pre-existing PNI

End stage renal failure

Hypertension

Age

Duration of surgery

Table 3. 7 Results of univariate multiple regression analysis
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Appendix A: List of Abbreviations
ANOVA

Analysis of variance

AVR

Aortic valve replacement

BMI

Body Mass Index

CABG

Coronary artery bypass grafting

CCS

Conventional cardiac surgery

CPB

Cardiopulmonary bypass

EMG

Electromyogram

HSREB

Health science research ethics board

ITA

Internal thoracic artery

LAD

Left anterior descending artery

LM

Left median

LU

Left ulnar

RM

Right median

RU

Right ulnar

MICS

Minimally invasive cardiac surgery

OR

Operating room

PCI

Percutaneous coronary intervention

POD

Post-operative day

PNI

Peripheral nerve injury

SSEP

Somatosensory evoked potential

TAVI

Transcatheter aortic valve implantation

RCT

Randomized controlled trial
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Appendix B: Letter of Information
Principle

Satoru Fujii

Investigator
Researchers:

Dr John Murkin, Professor, Department of Anesthesiology, LHSC
Dr Jason Chui, Department of Anesthesiology, LHSC
Dr Mackenzie Quantz, Associate Professor, Department of Surgery, LHSC
Dr Linrui Guo Associate Professor, Department of Surgery, LHSC
Dr Neil McKenzie, Professor, Department of Surgery, LHSC
Robert Mayer, Research Associate, Department of Anesthesiology, LHSC

24 Hour

Please ask for the on-call Anesthesiologist and let them know that you are a study

Contact

participant under Dr. Chui.

Information:

Purpose of the

The purpose of this letter is to provide information to explain the problem we are

study:

studying and why we would like you to participate in this study so that you can make
an informed decision to participate.
Because you are undergoing cardiac surgery, and we know that cardiac surgery can
sometimes cause problems with the nerves to your arm and hand, you are invited to
participate in a study that will evaluate the ability of a non-invasive monitoring device
to detect whether any of the nerves in your arms are under too much pressure during
your surgery and whether this device will help reduce such problems.
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Study

During cardiac surgery when you are under the anesthetic, the surgeon will require

Summary:

that your arms or chest are moved in a certain way in order to facilitate the surgery.
One of the instruments the surgeons need to use is a retractor that pulls on your
chest and this can interfere with nerves going to your arm. Since you are
unconscious you cannot tell the surgeon if that position is causing pressure on a
nerve and this can cause weakness, numbness or tingling in your hand after the
surgery. This is called a ‘positional neuropraxia’ or peripheral nerve injury (PNI).
Various studies in cardiac surgery have estimated this can occur in 1 in 100 or as
many as 1 in 3 patients. Usually these symptoms are mild and do not last more than
a few weeks but in some patients they may be more severe and long lasting.
This automated device uses a very tiny electrical signal (SSEP) - which is less strong
than the tingle you would get from a flashlight battery, to measure how well the
nerves in your arms are working during your operation and can detect pressure on
the nerve and gives an alert signal. We want to determine how many patients get
nerve injury during surgery undergoing two types of surgeries.
It is expected that in total, we will enroll about 100 patients undergoing cardiac
surgery for this study.

Study

If you agree to participate, before your surgery and 0 to 5 days afterwards we will do

procedures:

an upper limb neurological exam that takes less than 10 minutes. For this we will ask
you how your arms and hands are feeling and then we will assess the strength in

If you agree to

your arm by asking you to pull or push your arms and then your hands against the

participate, an

examiners arm. We will also ask you to open and close your fingers and will use a
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additional 10ml

blunt point (paper clip) to determine whether sensation in your arms and hands is

of blood will be

similar throughout or whether there are areas of different or missing sensation.

taken at the

While you are in the operating room we will put adhesive sensors on each wrist and

same time as

at base of your neck and forehead to measure the function of your arm nerves using

routine daily

SSEP during surgery. You will be actively monitored by this device.

blood work,

We will also collect data from your chart including your diagnosis, age, gender, vital

without the

signs, routine laboratory data, and the result of your hospitalization. We will not be

need for

ordering any additional blood-work or tests for the purposes of this research.

additional
needle stabs.
We will also
collect data
from your chart
including your
diagnosis, age,
gender, vital
signs, routine
laboratory data,
culture results
and the result
of your ICU
care.
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Alternatives to

Currently there are no alternatives for monitoring the nerve functions in your arm

Study

routinely during anesthesia and cardiac surgery. As our standard of care we always

Participation

employ our best efforts to pad your arms and minimize the amount of surgical
retractor use but currently we cannot tell whether this is sufficient to prevent nerve
injury.

Risks and

There are no known risks associated with this study since you will NOT be exposed

benefits

to any other additional procedures, tests or treatments and all the sensors are self-

associated with

adhesive and non-invasive. This information may potentially benefit patients in the

study:

future as this information may lead to better medical treatment of patients undergoing
cardiac surgery

Conflict of

As a member of the device’s Scientific Advisory Board Dr Murkin has received

Interest

corporate stock options

Right to ask

If you have any questions concerning this study, contact Dr Satoru Fujii at 519-685-

questions:

8500 pager 19147 or Rob Mayer pager18481. If you have any questions about the
conduct of this study or your rights as a research subject you may contact Dr. David
Hill, Scientific Director, Lawson Health Research Institute at (519) 667-6649.

Voluntary

Participation in this study is voluntary. You may refuse to participate in this study with

participation:

no effect on your current or future care. You may also choose to withdraw from this
study at any time and no further study procedures or data will be collected from you

If you have any

or your chart.

questions
concerning this
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study, contact
Dr. Tina Mele, If
you have any
questions
about the
conduct of this
study or your
rights as a
research
subject you
may contact Dr.
J. Gilbert, VP
Research and
Development at
London Health
Sciences
Centre.
Confidentiality:

Your confidentiality will be respected. Your research records will be stored on a
computer that is password-protected and not accessible by a network. No personal
identifying data will be retained or stored. Only your birth year and month and
hospital chart number will be collected and assigned a research code number. A
master list with this information will be stored in a separate, locked cabinet. No
information that discloses your identity will be released or published without your
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specific consent to the disclosure. However, it is important to note that the original
signed research consent form will be included in your health record. A copy of the
Letter of Information will be given to participants of the study to keep.
Representatives of the research team may require access to your records for the
purpose of monitoring the study. Representatives of Lawson Quality Assurance (QA)
Education Program may look at study data for QA purposes. The University of
Western Ontario Health Sciences Research Ethics Board (HSREB) may contact you
directly to ask about your participation in the study. Care will be taken to protect
confidentiality and while we will not voluntarily breach confidentiality, research
records may well be subject to subpoena and to disclosure by operation of law.
Because this device is approved for this clinical research study but is not yet licensed
for sale, Health Canada, and the US Office of Human Research Protection and Food
and Drug Administration may also look at this study data.
You do not waive any of your legal rights by signing the Consent Form
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CONSENT FORM
Investigators: Dr. John Murkin, Dr. Satoru Fujii, Dr. Jason Chui, Dr. Mackenzie Quantz, Dr. Linrui Guo, Dr.
Neil McKenzie, Dr. Roberto Lima, Robert Mayer,.
Department of Anesthesia and Perioperative Medicine
London Health Sciences Center
Schulich School of Medicine
University of Western Ontario

I have read the Letter of Information, have had the nature of the study explained to me and I agree to
participate. All questions have been answered to my satisfaction. I understand I will receive a copy of the
Letter of Information and signed and dated Consent Form.

I consent to the use of data collected from me in future studies related to this topic.

I do not consent to the use of data collected from me in future studies related to this topic.

Print Name:

___________________________________________

Signature:

___________________________________________

Date:

________________________
YYYY /

MM / DD

I confirm that I have explained the nature of the above investigation to the above-named patient.
Person Obtaining Informed Consent:
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Print Name:

___________________________________________

Signature:

___________________________________________

Date:

________________________
YYYY /

MM / DD
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Appendix C: Data Collection Forms
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